Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TerrAscend (TSNDF) Cash & Equivalents (2021 - 2025)

TerrAscend (TSNDF) has disclosed Cash & Equivalents for 5 consecutive years, with $37.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 6073.93% to $37.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.4 million through Dec 2025, up 6073.93% year-over-year, with the annual reading at $37.4 million for FY2025, 6073.93% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $37.4 million at TerrAscend, up from $36.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $88.4 million in Q1 2022, with the low at $605000.0 in Q2 2022.
  • Average Cash & Equivalents over 5 years is $29.1 million, with a median of $26.7 million recorded in 2025.
  • The sharpest move saw Cash & Equivalents plummeted 97.62% in 2024, then soared 6073.93% in 2025.
  • Over 5 years, Cash & Equivalents stood at $79.6 million in 2021, then plummeted by 67.16% to $26.2 million in 2022, then dropped by 14.97% to $22.2 million in 2023, then tumbled by 97.28% to $606000.0 in 2024, then skyrocketed by 6073.93% to $37.4 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $37.4 million, $36.5 million, and $26.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.